Similarly, in ccRCC, CPA4 was overexpressed in TCGA, GEO, and clinical samples (n = 24), with higher levels linked to advanced TNM stage, poor histological grade, and worse survival outcomes [41]. The gene discussed is CPA4; the disease is nonpapillary renal cell carcinoma.